Skip to main content
. 2020 Sep 22;64(Suppl 4):S235–S241. doi: 10.4103/ija.IJA_91_20

Table 3.

Incidence of adverse events

Adverse Events Group N (number and percentage) (n=84) Group M (number and percentage) (n=84) P
Nausea/Vomiting 7 (8.33%) 8 (9.5%) 0.7908
Shivering 9 (10.7%) 9 (10.7%) 1.000
Headache 6 (7.14%) 5 (5.95%) 0.7559
High Spinal/Total Spinal 0 0
Hypertension 0 0